Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antibody responses of man to three types of antityphoid immunizing agents: heat-phenol fluid vaccine, acetone-dehydrated vaccine, and isolated Vi and O antigens.

× No keyword cloud information.

8 in total

1. Studies on Vi antigen. VI. Immunization of human beings with purified Vi antigen.

Authors: M LANDY
Journal: Am J Hyg Date: 1954-07

2. Studies on Vi antigen. IV. Physicochemical characterization of Vi antigens isolated from V form Enterobacteriaceae.

Authors: M E WEBSTER; J F SAGIN; P R ANDERSON; S S BREESE; M E FREEMAN; M LANDY
Journal: J Immunol Date: 1954-07 Impact factor: 5.422

3. Studies on Vi antigen. V. Comparison of the immunological properties of Vi antigens derived from V form Enterobacteriaceae.

Authors: M LANDY; M E WEBSTER; J F SAGIN
Journal: J Immunol Date: 1954-07 Impact factor: 5.422

4. Estimation of Vi antibody employing erythrocytes treated with purified Vi antigen.

Authors: M LANDY; E LAMB
Journal: Proc Soc Exp Biol Med Date: 1953-04

5. Enhancement of the immunogenicity of typhoid vaccine by retention of the V1 antigen.

Authors: M LANDY
Journal: Am J Hyg Date: 1953-09

6. Studies on Vi antigen. I. Relative Vi antigen content of V form cultures.

Authors: M LANDY
Journal: Proc Soc Exp Biol Med Date: 1952-05

7. Studies on Vi antigen. II. Purification of Vi antigen from Escherichia coli 5395/38.

Authors: M E WEBSTER; M LANDY; M E FREEMAN
Journal: J Immunol Date: 1952-08 Impact factor: 5.422

8. Studies on Vi antigen. III. Immunological properties of purified Vi antigen derived from Escherichia coli 5396/38.

Authors: M LANDY; M E WEBSTER
Journal: J Immunol Date: 1952-08 Impact factor: 5.422

8 in total

11 in total

1. Laboratory tests of typhoid vaccines used in a controlled field study.

Authors: G EDSALL; M C CARLSON; S B FORMAL; A S BENENSON
Journal: Bull World Health Organ Date: 1959 Impact factor: 9.408

2. Protection of mice by living Vi and O vaccines against death caused by Salmonella paratyphi C.

Authors: G T ARCHER; J L WHITBY
Journal: J Hyg (Lond) Date: 1957-12

3. Chrome typhoid vaccine.

Authors: E E Vella
Journal: J Hyg (Lond) Date: 1963-03

4. Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin.

Authors: R K Gupta; S C Szu; R A Finkelstein; J B Robbins
Journal: Infect Immun Date: 1992-08 Impact factor: 3.441

5. History of vaccination.

Authors: Stanley Plotkin
Journal: Proc Natl Acad Sci U S A Date: 2014-08-18 Impact factor: 11.205

Review 6. On vaccines and vaccination: typhoid-paratyphoid fevers.

Authors: W Vella
Journal: Postgrad Med J Date: 1972-02 Impact factor: 2.401

7. Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.

Authors: D N Taylor; A C Trofa; J Sadoff; C Chu; D Bryla; J Shiloach; D Cohen; S Ashkenazi; Y Lerman; W Egan
Journal: Infect Immun Date: 1993-09 Impact factor: 3.441

8. SEROLOGICAL RESPONSES OF MAN TO TYPHOID VACCINES.

Authors: A S BENENSON
Journal: Bull World Health Organ Date: 1964 Impact factor: 9.408

Review 9. The COVID-19 Vaccine Landscape.

Authors: Till Koch; Anahita Fathi; Marylyn M Addo
Journal: Adv Exp Med Biol Date: 2021 Impact factor: 2.622

10. Studies on infection and immunity in experimental typhoid fever. III. Effect of prophylactic immunization.

Authors: S GAINES; M LANDY; G EDSALL; A D MANDEL; R J TRAPANI; A S BENENSON
Journal: J Exp Med Date: 1961-09-01 Impact factor: 14.307